Skip to main navigation Skip to search Skip to main content

An open-label, pilot trial of adjunctive tocilizumab in schizophrenia

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)275-276
Number of pages2
JournalJournal of Clinical Psychiatry
Volume77
Issue number2
DOIs
StatePublished - Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this